
ADHD therapies, and the NHS gig economy
About this episode
There is an enormous amount of research on treatment for ADHD - pharmaceutical and otherwise. But not all of those trials, or meta-analyses, are of high quality; and not many compare the whole literature.
Now a new umbrella review - a review of reviews - tries to give a broad overview of the whole evidence base. Corentin Gosling, associate professor at the Université Paris Nanterre, joins us to set out the benefits and harms of ADHD therapies.
Also, the BMJ’s been investigating the employment of doctors on “local” contracts in the NHS - and our latest look at this exposes what some have described as a “gig economy”, with doctors plugging rota gaps but missing out on training, development, and salary progression. Rebecca Coombes, head of journalism at The BMJ explains more.
Finally, Tom Frieden is former head of the US Centers for Disease Control, and current CEO of Resolve to Save Lives - he’s written a new book on public health. He joins us to talk about what actually improves health at a population level, and why the current US administration’s approach to staffing the CDC is leaving the country open to danger.
Reading list
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making
Revealed: Thousands of NHS doctors are trapped in insecure “gig economy” contracts
Get every episode summarized
Each time Medicine and Science from The BMJ publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Medicine and Science from The BMJ

What should GP's make of the new NHS contract?
Medicine and Science from The BMJ

Household air pollution, Labour’s lag on child poverty, children forced to cope...
Medicine and Science from The BMJ

Measles is surging in 2026. From London to Texas, why are cases hitting a 30-yea...
Medicine and Science from The BMJ

Rethinking Cancer Survivorship and the Autism Gender Gap
Medicine and Science from The BMJ
